By A Mystery Man Writer
A Blocking Peptide for Anti-KCNE1/IsK Antibody
KCNN1/KCa2.1 Blocking Peptide, BLP-PC039
The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9
Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease.
PCSK9 - Wikipedia
KCNE1 is an auxiliary subunit of two distinct ion channel superfamilies - ScienceDirect
KCNE1 is an auxiliary subunit of two distinct ion channel superfamilies - ScienceDirect
The emerging landscape of peptide-based inhibitors of PCSK9 - ScienceDirect
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor - IRBM
Frontiers Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review
Kv1.1/KCNA1 Blocking Peptide, BLP-PC009
Frontiers BK Channel Dysfunction in Diabetic Coronary Artery: Role of the E3 Ubiquitin Ligases
Association of Circulating Tissue Inhibitor of Metalloproteinases‐1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease